Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to -$3000.0.

  • International Stem Cell's Cash from Investing Activities rose 9250.0% to -$3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$43000.0, marking a year-over-year increase of 7485.38%. This contributed to the annual value of -$171000.0 for FY2024, which is 10602.41% down from last year.
  • Latest data reveals that International Stem Cell reported Cash from Investing Activities of -$3000.0 as of Q3 2025, which was up 9250.0% from -$32000.0 recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Cash from Investing Activities registered a high of -$2000.0 during Q1 2021, and its lowest value of -$119000.0 during Q2 2024.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$9000.0 (2024), whereas its average is -$20352.9.
  • In the last 5 years, International Stem Cell's Cash from Investing Activities surged by 9512.2% in 2021 and then plummeted by 25000.0% in 2023.
  • Quarter analysis of 5 years shows International Stem Cell's Cash from Investing Activities stood at -$18000.0 in 2021, then skyrocketed by 83.33% to -$3000.0 in 2022, then changed by 0.0% to -$3000.0 in 2023, then changed by 0.0% to -$3000.0 in 2024, then changed by 0.0% to -$3000.0 in 2025.
  • Its last three reported values are -$3000.0 in Q3 2025, -$32000.0 for Q2 2025, and -$5000.0 during Q1 2025.